MedPath

Randomized Double-blind, Placebo-controlled multi-center trial on molecular hydrogen water in Parkinson Disease

Not Applicable
Conditions
Parkinson&#39
s disesase
Registration Number
JPRN-UMIN000010014
Lead Sponsor
Juntendo University School of Medicine, Neurology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. The patient has parkinsonism due to corticobasal syndrome, multiple system atrophy, drug parkinsonism, hydrocephalus, or essential tremor. 2. The presence of other serious disease. 3. The presence of malignant tumor. 4. The presence of adverse event caused by levodopa or dopamine agonist. 5. Pregnant woman 6. Allergy for drugs. 7.The subjects who is inappropriate for the study according to our judgment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath